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ABSTRACT 
Recent studies suggest that normobaric hyperoxia (HO) protects the rat brain from ischemia 
reperfusion (IR) injury. Protein kinase C (PKC) is a key signaling molecule involved in pro-
tection against IR injury but its role in protective effect of HO in brain injury in unknown. In 
this study we attempted to see if PKC is involved in the effect of HO. Rats were divided into 
four main experimental groups. The first two were exposed to 95 % oxygen (HO) in a cham-
ber 4 h/day for 6 consecutive days. Each of these groups had a control group exposed to 21 % 
oxygen. To investigate the role of PKC during HO, chelerythrin chloride (CHEL, 
1 mg/kg/day), a PKC inhibitor, or its vehicle was given to animals for 6 days. After 24 h, the 
rats were subjected to 60 min of right middle cerebral artery occlusion (MCAO). After 24 h 
reperfusion neurological deficit scores, infarct volume, brain edema and blood–brain Barrier 
(BBB) permeability were assessed. HO decreased the infarct volume and brain edema in 
comparison with controls. PKC inhibition was associated with a significant increase in infarct 
size in both HO and control animals. PKC inhibition was unable to change brain edema in the 
experimental groups. Both HO and PKC inhibition reduced the BBB permeability within 24 h 
post occlusion of middle cerebral artery. Although both HO and PKC inhibition were associ-
ated with inhibition of BBB permeability during ischemic brain injury in rats, the neuropro-
tective effect of HO was independent of PKC in the MCAO model. 
 
Keywords: normobaric hyperoxia, ischemic preconditioning, stroke, neuroprotection, PKC, 
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INTRODUCTION 
Ischemic stroke is the major cause of 
morbidity and mortality in modern society 
(Murray and Lopez, 1997). Ischemic pre-
conditioning (IPC) is an endogenous phe-
nomenon that whereby brief periods of is-
chemia, causes a tissue more resistant to 
subsequent sustained loss of blood flow and 
can induce ischemic tolerance (IT) in a va-
riety of organ systems such as the heart and 
brain (Kitagawa et al., 1990). Ischemic tol-
erance involves mediating mechanisms 
such as the synthesis of new protective pro-
teins, anti-oxidant enzymes, growth factors, 
or anti-apoptotic gene products (Chen and 
Simon, 1997; Kato et al., 1992; Perez-
Pinzon et al., 1996; Kirino, 2002; Ohtsuki 
et al., 1992). Recent studies suggest that 
normobaric hyperoxia (HO) protects the rat 
brain tissue from ischemia reperfusion (IR) 
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injury (Bigdeli et al., 2007). The mecha-
nism of this effect is not well understood 
but it appears that enhancement of endoge-
nous defense mechanisms are involved.  
Protein kinase C (PKC) is a ubiquitous 
histone protein kinase activated by phos-
pholipids, diacylglycerol (DAG) and Ca2+  
(Hoshida et al., 1993), this family of en-
zymes has been implicated as an important 
signal transduction pathway for many cellu-
lar and physiological events such as en-
hancement of neurotransmitter  release, de-
sensitization of receptors and modulation of 
ion channels (Tahepold et al., 2003). PKC 
is a key signaling molecule involved in pro-
tection against ischemia reperfusion (IR) 
injury. PKC activation might be a common 
signal transduction factor in both heart and 
brain which initiates different signaling 
pathways during IPC-induced tolerance 
(Perez-Pinzon et al., 2005). PKC is abun-
dant in neural cells; the heterogeneous 
topographical distribution of PKC is formed 
within particular brain regions and is re-
ferred to special activities (Thornton et al., 
1990). When PKC is activated with phorbol 
esters, transcription factor activator protein-
1 (AP-1) is bounded to TRE which is its 
BNA binding site. It was demonstrated that 
this binding of AP-1 to DNA and DNA ac-
tivation is sensitive to changes in its oxida-
tion-reduction status (Hoshida et al., 1993), 
and that PKC-specific activity is increased 
in response to reactive oxygen species 
(Thornton et al. 1990). When cells were 
exposed to 95 % O2 for 5 days, a 2-fold in-
crease PKC specific activity has been ob-
served (Perez-Pinzon et al., 2005). 
In spite of above information, the role 
of PKC in the induction of the ischemic tol-
erance by HO is still not well understood. 
Activation of PKC by oxidants, prompted 
us to investigate the potential role of PKC 
under HO in rat brain stroke model.  
 
MATERIAL AND METHODS 
Adult male Wistar rats (250-350 g) 
were housed under conditions of controlled 
temperature (22 ± 2 °C) and constant hu-
midity, with 12 h light/dark cycle (light on 
07:00–19:00) for all experiments. All ex-
perimental animal procedures were con-
ducted with the approval of the Ethics 
Committee of the Tarbiat Modares Univer-
sity. Every effort was made to minimize the 
number of animals used and their suffering.  
Chelerythrin chloride (CHEL, 1.0 mg/ 
kg/day) was dissolved in sterile saline and 
was subcutaneously injected to the rats for 
6 days, 20 minutes before housing the ani-
mals in the normobaric chamber. 
Rats were divided randomly into 4 main 
groups (n=18 animals in each group). Two 
of these groups were placed in an environ-
mental chamber and exposed to a hyperoxic 
atmosphere (95 % oxygen: normobaric hy-
peroxic groups, or HO), for 4 continuous 
hours for six consecutive days. The first 
group received daily injection of CHEL 
20 min prior to HO and the other one was 
given daily injection of vehicle (saline). 
The two other groups were similarly placed 
in the environmental chamber and exposed 
to room-air (RA) equivalent (21 % oxygen: 
normobaric normoxic groups) for similar 
time periods. Each group was subdivided 
for evaluation of infarct volume, brain wa-
ter content measurement and blood–brain 
barrier (BBB) permeability. In addition of 
the main groups, we included 2 sham oper-
ated groups (n=12 animals in each group). 
One of these groups was used for evalua-
tion of brain water content and another for 
measurement of BBB permeability. HO 
treatment was initiated in the chamber 
(650×350×450 mm3). Oxygen concentra-
tion inside the container was continuously 
monitored using an oxygen sensor (Lutron-
Do5510, Taiwan), and soda lime; a carbon 
dioxide absorber was used (BDH Limited, 
Poole, UK) at the sides of the chamber. The 
two other groups were similarly placed in 
the environmental chamber and exposed to 
RA (21 % oxygen). Oxygen concentration 
was maintained at 95 % or 21 % according 
to the experimental protocol. 
At the beginning of day 7 after induc-
tion of HO, animals were anesthetized with 
chloral hydrate (400 mg/kg) and were sub-
jected to middle cerebral artery occlusion 
(MCAO) as described (Longa et al., 1989). 
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In brief, the right common carotid artery 
(CCA) was carefully separated from the 
vagus nerve and surrounding tissues. Using 
microscopic surgery, a 3-0 silicone coated 
nylon suture was introduced through the 
external carotid artery stump. The occluder 
was advanced into the internal carotid ar-
tery (ICA) 20–22 mm beyond the carotid 
bifurcation until mild resistance indicated 
that the tip was lodged in the anterior cere-
bral artery and blocked the blood flow to 
the middle cerebral artery (MCA). Rectal 
temperature was monitored (Citizen-513w) 
and maintained at 37 °C by surface heating 
and cooling during surgery. The body tem-
perature, blood gases, heart rate were main-
tained within the physiologic range 
throughout the operation. Continuous La-
ser–Doppler flowmetry (LDF; Moor In-
strument, UK) was used to monitor cerebral 
perfusion to ensure adequacy of MCAO 
through the CCA until the Laser-Doppler 
signal showed a steep decrease (more than 
75 % reduction of cerebral blood flow is 
necessary for successful induction of is-
chemia). Reperfusion was started by remov-
ing the suture after 1 hour of ischemia. The 
sham operated rats were subjected to the 
same surgical procedures except the fila-
ment insertion. 
After the operation, the rats were re-
turned to their separate cages. 24 h after 
surgery, the rats were assessed neurologi-
cally by an observer who was blind to the 
animal groups. The neurobehavioral scoring 
was performed using a six-point scale 
(Longa et al., 1989): normal motor func-
tion=0; failure to extend left forepaw ful-
ly=1; circling to the contralateral side but 
have normal posture at rest=2; falling to the 
left, a severe focal deficit=3; rats that did 
not walk spontaneously and had a depressed 
level of consciousness=4. Death was con-
sidered as score 5 only when a large infarct 
volume was present in the absence of sub-
arachnoid hemorrhage. If the rats died due 
to subarachnoid hemorrhage or pulmonary 
insufficiency and asphyxia, they were elim-
inated from the study. 
After scarification of rats with chloral 
hydrate (800 mg/kg), the animals were de-
capitated and the brains were rapidly re-
moved and cooled in 4 °C saline for 
15 minutes. Eight 2-mm-thick coronal sec-
tions were cut using a rat brain matrix 
through the brain, beginning at the olfactory 
bulb. The slices were immersed in 2 % 
2,3,5-triphenyltetrazolium chloride solution 
(Merck, Germany), and kept at 37 °C in a 
water bath for 15 min. The slices were then 
photographed by a digital camera (Canon 
SX210IS, Japan) connected to a computer. 
Unstained areas were defined as infarct, and 
were measured using image analysis soft-
ware (Image Tools, NIH, USA). The infarct 
volume was calculated by measuring the 
unstained and stained area in each hemi-
sphere slice, and multiplied by slice thick-
ness (2 mm), and then summating all of the 
eight slices according to the method of 
Swanson (Swanson et al., 1990): corrected 
infarct volume=left hemisphere volume− 
(right hemisphere volume − infarct vol-
ume). 
After decapitation, the brain was re-
moved. The cerebellum, pons, and olfactory 
bulb were separated and their wet weights 
(WW) measured (Bigdeli et al., 2007). Dry 
weights (DW) were assessed after 24 h at 
120 °C. Brain water content (BWC) was 
calculated as [(WW−DW)/WW] ×100. 
The integrity of BBB was evaluated by 
using Evans Blue (EB, Sigma Chemicals, 
USA) dye extravasations (Kaya et al., 
2003). Briefly, the rats received 4 ml/kg of 
2 % EB solution in saline by tail vein injec-
tion 30 min after MCAO. 24 h after reper-
fusion, the thoracic cavity was opened un-
der anesthesia. The rats were perfused with 
250 ml saline transcardially to wash out in-
travascular EB until colorless perfusion flu-
id was obtained from the atrium. After de-
capitation, the brains were removed and the 
hemispheres separated and weighed. The 
right and left hemispheres were separately 
homogenized in 2.5 ml phosphate-buffered 
saline to extract the EB, and to precipitate 
protein 2.5 ml of 60 % trichloroacetic acid 
was added and mixed by vortex for 3 min. 
The samples were then placed at 4 °C for 
30 min and centrifuged for 30 min at 
1000×g. The amount of EB in the superna-
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tants was measured at 610 nm using spec-
trophotometer (Genova, Jenway). EB levels 
were expressed as μg/g of brain tissue 
against a standard curve (Bigdeli et al., 
2007). 
Data were expressed as means ± SEM.  
Infarct volumes and EB extravasations, 
brain water content and arterial blood gases 
(ABG) were compared using two-way 
ANOVA test. The neurologic deficit scores 
(NDS) were analyzed using the Bonferoni 
post-hoc test. P<0.05 was considered signif-
icant. 
 
RESULTS 
Figure 1 shows oxygen content (%) in 
the container in HO and normoxia condi-
tions. Arterial blood gas analysis confirmed 
clinical HO in the treated groups (Table 1). 
Figure 1: Oxygen concentration in the hyperox-
ia-inducing chamber during hyperoxia (HO) in 
comparison with room air (RA) 
As shown in Figure 2, MCAO was able 
to reduce regional cerebral blood flow to 
less than 25 % of that at baseline. 
 
Figure 2: Regional cerebral blood flow (rCBF) 
before and during middle cerebral artery occlu-
sion (MCAO), and after reperfusion (n=6) 
 
CHEL increased the neurologic deficit 
scores (NDS) in groups of normoxia and 
HO. In the group of normoxia this increase 
was greater. The median of NDS was 2.12 
(range: 0–4), 0.83 (range: 0–2), 3.08 (range: 
1–4) and 1.95 (range: 0–4) in the HO, HO-
CHEL, RA-CHEL and RA groups, respec-
tively (Table 2). The harmful effects of 
CHEL were confirmed by an increase in 
infarct volume (Figure 2). 
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Table 1 – ABG tests at the end of pretreatment 
Experimental 
groups pH PCO2(mmHg) PO2(mmHg) Heart rate 
Blood 
pressure 
(mmHg) 
Respiratory 
rate (Hz) 
 RA 7.4±0.01 41.7±1.8 93.6±6.2 357.97±28.44 84.44±26.03 1.42±0.03 
 HO 7.3±0.01 39.9±1.4 365.4±22.1 
*** 
363±12.01 83.13±.22.3 1.69±0.09 
 RA CHEL 7.4±0.02 41.8±1.6 93.5±4.2 347±1.63 80.33±10.29 1.12±0.13 
 HO CHEL 7.31±0.08 40.4±1.98 366±15.7 
*** 
353±.07 82..04±5.51 1.38±0.11 
*** P<0.001. 
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The putative beneficial effects of HO 
were confirmed by a reduction in infarct 
volume (Figure 3). Pretreatment with 
CHEL resulted in an increase of infarct 
volume. 
 
 
Figure 3: Photographs showing the neuropro-
tective effect of hyperoxia on focal cerebral is-
chemia. All sections of the brain were stained 
with TTC at 24h after 60 min of ischemia. Each 
column presents the series of rat brain coronal 
sections: (A) Brain sections of control rats, (B) 
Brain sections of rats with HO, (C) Brain sec-
tions of rats with HO + CHEL and (D) Brain sec-
tions of CHEL in stroke groups. 
 
 
 
Figure 4A shows the effect of HO on in-
farct volume in whole brain. Statistical 
analysis using two-way ANOVA showed 
that HO induced a significant reduction in 
infarct volume in comparison with RA 
groups (FHO vs RA=14.19, P<0.05). CHEL 
significantly increased infarct volume in 
both groups (FCHEL vs vehicle=9.896, P<0.05). 
The effect of HO on infarct volume did not 
show a significant interaction with the PKC 
inhibition (Finteraction=0.157, P=0.695). Fig-
ure 4B shows the effect of HO on infarct 
volume in the cortical layer. Likewise, HO 
induced a significant reduction in infarct 
volume in comparison with RA group (FHO 
vs RA=19.44, P<0.001). CHEL significantly 
increased infarct volume in the cortical lay-
er in both groups (FCHEL vs vehicle=10.88, 
P<0.01). However, the effect of HO on in-
farct volume did not show a significant in-
teraction with CHEL (Finteraction=0.592, 
P=0.4506). In the subcortical area, as 
shown in Figure 4C, there was no signifi-
cant difference between the groups (FHO vs 
RA=3.015, P=0.098, FCHEL vs vehicle=1.114, 
P=0.307, Finteraction=0.073, P=0.789).  
Table 2: The distribution of neurologic deficit score in each groups 
 
No.    Experimental groups       NDS in each groups(N)     Total (N)      Median   Statistical results  
 (P value) 
 
 0 1 2 3 4  
1  RA 0 4 14 5 1 24 2.12  
1:2 sig. (0.000) 
1:3 sig. (0.000) 
2  HO 10 8 6 0 0 24 0.83  
2:3 sig. (0.000) 
2:4 sig. (0.02) 
3  RA-CHEL 0 1 5 9 9 24 3.08  3:4 sig. (0.03) 
4 HO-CHEL  4 5 8 2 5 24 
1.95 
 4:1 nosing. (0.519) 
5 Total 14 18 33 16 15 96 -  
NDS: neurologic deficit score; N: the number of cases in each groups; sig.: significant; nonsig.:  
non-significant; RA: Room Air; HO: Hyperoxia; CHEL: Chelerythrin Chloride 
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Figure 4: The effect of hyperoxia on infarct vol-
ume in different experimental groups. Results 
were confirmed by infarct volumetry: whole 
brain (A), cortex (B), and subcortex (C) area of 
brain (n=6) 
 
Figure 5 shows the effect of HO and 
CHEL on brain water content which is an 
indicator of brain edema. Data are ex-
pressed as the difference between the left 
and right hemispheres. HO significantly 
decreased brain edema in comparison with 
RA animals (FHO vs RA=11.79, P<0.01). The 
effect of CHEL on brain edema was not sta-
tistically significant in the experimental 
groups (FCHEL vs vehicle=0.0005, P=0.982). 
And there was no significant interaction 
between HO and CHEL on brain edema 
induced by MCAO (Finteraction=0.711, 
P=0.409). 
 
Figure 5: Difference between right and left 
hemisphere water content (WR–WL) in rats 
given room air (RA), hyperoxia (HO) in CHEL or 
vehicle treated groups (n=6) 
 
The effect of HO and CHEL on BBB per-
meability is shown in Figure 6. MCAO was 
able to increase the BBB permeability in 
the experimental groups in both cortical and 
subcortical areas (Figure 6A and 6B). In 
cortical areas, HO was able to significantly 
decrease BBB permeability in comparison 
with RA groups (FHO vs RA=37.6, P<0.0001). 
Likewise, PKC inhibition was associated 
with a significant reduction in BBB perme-
ability in both groups (FCHEL vs vehicle=20.11, 
P<0.0001). Moreover, the effect of HO on 
BBB protection showed a significant inter-
action with CHEL (Finteraction=11.87, 
P=0.0001). The effect of HO and CHEL 
was similar in the subcortical and cortical 
areas (FHO vs RA=62.48, P<0.0001; FCHEL vs 
vehicle=20.97, P<0.0001; Finteraction=12.58, 
P=0.0001). 
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Figure 6: Blood brain barrier permeability in 
various experimental groups. EBR: Evans blue 
extravasation right; EBL: Evans blue extravasa-
tions left. Cortex (A), subcortex (B) (n = 6) 
 
DISCUSSION 
We have previously shown that inter-
mittent and prolonged HO induces ischemic 
tolerance, as demonstrated by decreases in 
infarct volume, neurological deficit scores, 
brain edema, and BBB permeability 
(Bigdeli et al., 2007). Ischemic tolerance 
also decreases excitotoxicity via reduction 
of extracellular glutamate in rat brain 
(Grabb et al., 2002). We have also previ-
ously demonstrated that preconditioning 
with prolonged and intermittent normobaric 
HO up-regulates glutamate transporters 
(EAAT1, EAAT2, EAAT3, and TACE) and 
serum TNFα level as well as phospho-IkB 
level in rat brain (Bigdeli et al., 2009). The 
MCAO ‘suture’ model used in this study is 
a reliable and reproducible model (Longa et 
al., 1989) which induces less subarachnoid 
hemorrhage and hypothalamically-induced 
hyperthermia than the intraluminal filament 
model (Dittmar et al., 2003). To further 
study the mechanism of HO-induced is-
chemic tolerance, we used a rat model of 
HO and investigated the role of PKC in 
HO-induced ischemic tolerance. Our data 
suggest that PKC inhibitor in the cortical 
areas significantly increase infarct volume; 
indicating the importance of PKC in brain 
protection during stroke. HO significantly 
and without interaction with PKC reduced 
infarct size, this suggests the neuroprotec-
tive effect of HO on infarct size is inde-
pendent of PKC in the MCAO model. In 
the subcortical areas HO or CHEL didn’t 
have significant effect on infarct volume. 
The lack of protective effect of HO in the 
subcortical area could be due to the more 
severe damage in the subcortical areas than 
the cortical areas (Garcia et al., 1997).  
Previous studies have shown that NF-
κB inhibitors abrogate the infarct-limiting 
effect, which has been shown in both early 
and delayed phase of hyperoxic precondi-
tioning. The cellular mechanism by which 
IPC activates NF-κB is known to involve 
formation of reactive oxygen species (ROS) 
and activation of PKC and tyrosine kinase 
dependent pathways (Xuan et al., 1999).  
Cerebral ischemia/reperfusion injury ty-
pically causes the disruption of water ho-
meostasis, and an excess of water accumu-
lates in the brain parenchyma, causing brain 
edema, the serious sequelae of brain edema 
includes deficits in neurological function as 
well as increased intracranial pressure. Aq-
uaporins are homologous water-transport-
ing channel proteins. They provide the ma-
jor means of water permeability across 
plasma membranes. Among the family of 
aquaporin proteins, aquaporin 4 (AQP4) is 
the major water-selective channel in the 
central nervous system (Kobayashi et al., 
2004). It is extensively expressed in spe-
cialized cells that form the blood-brain and 
brain-cerebral spinal fluid interfaces, in-
cluding astrocyte end-feet that surround 
cerebral blood vessels, ependymal cells, 
and microvascular endothelial cells (Rash et 
al., 1998). Further work has shown that 
PKC is implicated in the regulation of 
AQP4 expression. For example in cultured 
astrocytes, the phorbol ester, 12-O-tetra-
decanoylphorbol 13-acetate (TPA), a PKC 
activator, reduced AQP4 mRNA and inhib-
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ited its biological activity (Yamamoto et al., 
2001). In support of previous work we in-
vestigated the effect of a PKC inhibitor on 
brain edema in a rat model of stroke. Our 
results showed that inhibition of PKC didn’t 
have a significant effect on brain water in 
the MCAO model. However, HO was able 
to decrease brain edema in rat, although this 
effect was independent of PKC. 
Our experiments in support of previous 
work showed that HO improves BBB func-
tion. The means through which HO im-
proves BBB integrity are not clear, but may 
hinge upon the production of ROS and 
TNF-α in the brain tissue (Currie and Tan-
guay, 1991). HO can lead to increase in free 
radical oxygen, the increase of free radical 
oxygen and superoxide dismutase is associ-
ated with decreased expression of hypoxia 
induced factor-1α, leading to improved 
blood brain barrier function via decreased 
vascular growth factor (Ostrowski et al., 
2005). PKC inhibitor significantly de-
creased BBB permeability. This finding 
corroborates with the recent reports which 
showed that activation of the various PKC 
isozymes have different effect on the integ-
rity of BBB. PKC has 11 isozymes, some of 
them (α, βІ, βΙІ) require Ca2+ for activation 
and other isozymes (μ, ε, η, δ, θ, ζ, λ) are 
independent of Ca2+. The Ca2+-induced of 
signaling pathways such as phosphorylation 
of actin-associated proteins and occluding 
is in agreement with changes in BBB func-
tion (Brown and Davis, 2002). When is-
chemia occurs α, βІ, βΙІ isozymes are active 
which increase permeability of the cerebral 
endothelial cells, and PKC inhibitor reduces 
this effect of PKC in brain areas, whereas 
through HO; μ, ε, η, δ, θ, ζ, λ are active, and 
protect the BBB integrity (Fleegal et al., 
2005).  
Another hypothesis is that PKC may in-
directly alter the tight junction proteins by 
activating a downstream intracellular sig-
naling pathway that in turn directly affects 
the tight junction proteins (Kumar et al., 
2009). Previous studies have demonstrated 
that changes in nitric oxide and intracellular 
Ca2+ may contribute to increases in paracel-
lular permeability (Brown and Davis, 2002; 
Fleegal et al., 2005). Ca2+ increases in the 
expression of the Ca2+-dependent isozymes 
PKC-βΙІ and PKC-γ along with PKC-ζ sug-
gest that PKC may interact with this signal-
ing molecule to contribute to BBB permea-
bility alterations (Banan et al., 2003). 
In summary, this is the first report 
showing the inhibition of PKC after normo-
baric HO in the rat brain, and its neuropro-
tective role in ischemic tolerance. These 
data indicate the importance of PKC activa-
tion in response to HO which is important 
in brain integrity; whereas effect of HO on 
brain edema and infarct volume is inde-
pendent of PKC in the MCAO model. And 
finally elucidation of other mechanisms that 
regulate the acquisition of brain ischemia 
tolerance may help in the development of 
effective methods of HO preconditioning to 
protect the brain or reduce ischemic injury. 
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